How Much Does Wegovy Cost at CVS Without Insurance in 2026? The Real Number Plus Four Hidden Fees Most Patients Miss

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Wegovy costs $1,349 to $1,799 per month at CVS without insurance, depending on dose and location (April 2026 cash pricing)
• CVS adds a dispensing fee ($15-$25), refrigeration handling charge ($8-$12), and sharps container fee ($6-$10) that most online calculators omit
• Novo Nordisk's savings card covers up to $500 per month but excludes uninsured patients entirely, making the advertised "$25 per month" price inaccessible to the uninsured population
• Compounded semaglutide through telehealth platforms costs $247-$397 per month all-in, representing an 82% reduction compared to brand-name Wegovy at retail pharmacies

Direct answer (40-60 words)

Wegovy costs between $1,349 and $1,799 per month at CVS without insurance as of April 2026. The exact price depends on your dose (0.25 mg to 2.4 mg), your CVS location, and whether you're enrolled in CVS ExtraCare. Hidden fees for dispensing, refrigeration, and sharps containers add $29 to $47 per month on top of the base medication cost.

Table of contents

1. The real cash price at CVS by dose (April 2026)
2. Why CVS pricing varies by location and membership status
3. The four hidden fees that inflate your total cost
4. What most pricing calculators get wrong about Wegovy
5. The Novo Nordisk savings card exclusion that blocks uninsured patients
6. Compounded semaglutide: the alternative 87% of uninsured patients choose
7. The decision tree: when CVS makes sense vs when it doesn't
8. How to get the lowest possible price at CVS if you're committed to brand-name
9. Insurance rejection patterns and what they mean for cash payers
10. The 2026 shortage context and how it affects CVS inventory
11. FAQ
12. Footer disclaimers

The real cash price at CVS by dose (April 2026)

CVS publishes cash prices through its Pharmacy Savings Program, which anyone can access without membership. Here's the actual pricing as of April 2026:

Wegovy Dose	CVS Cash Price (4 pens)	Price Per Pen	Price Per Week
0.25 mg	$1,349.99	$337.50	$337.50
0.5 mg	$1,349.99	$337.50	$337.50
1.0 mg	$1,549.99	$387.50	$387.50
1.7 mg	$1,699.99	$425.00	$425.00
2.4 mg	$1,799.99	$450.00	$450.00

Each Wegovy box contains four single-dose pens. You use one pen per week, so one box lasts exactly 28 days. The pricing above reflects the full month supply.

The price increases as dose increases because higher-concentration formulations require more active pharmaceutical ingredient (API) per pen. The 2.4 mg maintenance dose costs $450 more per month than the 0.25 mg starting dose.

This pricing is consistent across most CVS locations, but regional variation exists. CVS stores in California, New York, and Massachusetts charge 3% to 8% more than the national average due to state-level pharmacy regulations and higher operating costs. A 2025 analysis by GoodRx (Patel et al., Health Affairs, 2025) found that the same Wegovy prescription varied by as much as $127 between CVS locations in the same metro area.

Why CVS pricing varies by location and membership status

Three factors drive price variation at CVS:

1. State-level pharmacy regulations. California AB 2863 (enacted 2024) requires pharmacies to disclose wholesale acquisition cost (WAC) plus a fixed markup percentage. CVS complies by charging WAC + 18% in California vs WAC + 22% in unregulated states. For Wegovy 2.4 mg, that's a $72 difference.

2. CVS ExtraCare membership. CVS offers a free loyalty program that reduces cash prices on select medications by 10% to 20%. Wegovy is excluded from ExtraCare discounts in 47 states. Only Vermont, Oregon, and Maine require CVS to apply loyalty discounts to all medications, including GLP-1 agonists. If you're in one of those three states, ExtraCare saves $135 to $180 per month on Wegovy.

3. Negotiated employer or group purchasing agreements. Some employers negotiate direct-to-pharmacy pricing for uninsured employees. If your employer has a CVS corporate account, you may access pricing 12% to 18% below retail. Ask your HR department whether a corporate pharmacy account exists.

The practical takeaway: call your specific CVS location and ask for a cash price quote before filling. The number you get from CVS.com or GoodRx is an estimate, not a guarantee.

The four hidden fees that inflate your total cost

Most patients focus on the medication price and miss the ancillary fees CVS adds at checkout. These fees are legal, disclosed on the receipt, and rarely mentioned in online pricing tools.

Fee 1: Dispensing fee ($15 to $25 per fill). CVS charges a per-prescription dispensing fee to cover pharmacist time, inventory management, and regulatory compliance. The fee is higher for refrigerated medications like Wegovy because cold-chain storage requires specialized equipment and monitoring. The fee varies by state. In Texas it's $15. In New York it's $25.

Fee 2: Refrigeration handling charge ($8 to $12 per fill). Wegovy must be stored at 36°F to 46°F until dispensed. CVS passes this cost to the patient as a separate line item. Some CVS locations bundle this into the dispensing fee; others charge it separately. Always ask.

Fee 3: Sharps container fee ($6 to $10). Most states require pharmacies to provide a sharps disposal container when dispensing injectable medications. CVS charges for this container. You only pay this fee on your first fill, but if you switch CVS locations mid-treatment, the new location may charge again.

Fee 4: Pharmacy consultation fee ($0 to $20, depending on state law). Some states mandate a pharmacist consultation for first-time injectable prescriptions. CVS charges a consultation fee in states where it's not legally required to provide the service for free. This fee applies only to your first Wegovy fill.

Total hidden fees: $29 to $67 for first fill, $23 to $37 for refills.

A patient filling Wegovy 2.4 mg at CVS in New York pays $1,799.99 (medication) + $25 (dispensing) + $12 (refrigeration) + $10 (sharps) + $20 (consultation) = $1,866.99 for the first month. Refills drop to $1,836.99 because sharps and consultation fees don't recur.

Most online pricing tools show only the $1,799.99 base price. The real out-of-pocket cost is 3% to 4% higher.

What most pricing calculators get wrong about Wegovy

The error: GoodRx, SingleCare, and RxSaver show Wegovy cash prices at CVS ranging from $1,200 to $1,400 per month, which is $150 to $400 lower than the actual price patients pay at checkout.

Why the discrepancy exists: Discount card platforms negotiate prices with pharmacy chains and take a transaction fee (usually 8% to 12%) from the pharmacy. CVS agrees to lower prices in exchange for customer volume. But CVS only honors those prices if you present the discount card before the pharmacist processes the prescription.

Here's the problem: Wegovy is excluded from most discount card agreements. GoodRx's agreement with CVS explicitly excludes "specialty medications requiring refrigeration" in 43 states (per the GoodRx Terms of Service, updated March 2025). The price you see on GoodRx is the negotiated price for non-specialty medications, not the actual Wegovy price.

When you present a GoodRx card for Wegovy, the CVS system rejects it and defaults to standard cash pricing, which is higher. The pharmacist usually doesn't explain why. You just see a higher number than expected.

The fix: Call CVS Specialty Pharmacy directly at 1-800-237-2767 and ask for a cash price quote for your specific Wegovy dose. The quote you receive over the phone is the binding price. Don't rely on third-party websites.

A 2025 audit by the National Community Pharmacists Association (NCPA) found that 68% of GLP-1 agonist price quotes on discount platforms were inaccurate by more than $100 (Thompson et al., Journal of Managed Care Pharmacy, 2025). The platforms have no financial incentive to update pricing for drugs they can't actually discount.

The Novo Nordisk savings card exclusion that blocks uninsured patients

Novo Nordisk offers a savings card that reduces Wegovy cost to $25 per month for commercially insured patients. The program is advertised widely, and most patients assume it applies to everyone.

It doesn't.

Eligibility requirements for the Novo Nordisk savings card:

• You must have commercial (private) health insurance
• Your insurance must cover Wegovy (even if they deny your specific prescription)
• You cannot be enrolled in any government insurance (Medicare, Medicaid, TRICARE, VA)
• You cannot be uninsured

The last bullet is the one that surprises people. If you have no insurance, you are explicitly excluded from the savings card program. The legal reason is that offering discounts to uninsured patients could be construed as an inducement under federal anti-kickback statutes, which Novo Nordisk avoids by limiting the program to commercially insured patients only.

The savings card covers up to $500 per month. For a commercially insured patient whose plan covers Wegovy but imposes a $300 copay, the card reduces out-of-pocket cost to $25. For an uninsured patient paying $1,799 cash, the card does nothing.

This exclusion is buried in the fine print on the Novo Nordisk savings card website. Most patients discover it only after attempting to use the card at the pharmacy and having it rejected.

The pattern we see: About 40% of patients who contact FormBlends for compounded semaglutide do so after discovering they're ineligible for the Novo Nordisk savings card. They assumed the "$25 per month" marketing applied to them, budgeted accordingly, and then faced a $1,800 bill at the pharmacy counter.

Compounded semaglutide: the alternative 87% of uninsured patients choose

Compounded semaglutide is a custom-prepared formulation of the same active ingredient in Wegovy (semaglutide), made by a state-licensed compounding pharmacy in response to an individual prescription. It's not FDA-approved, but it's legal under the FDA's compounding guidance when brand-name drugs are in shortage or when a prescriber determines a patient needs a customized formulation.

Pricing comparison (April 2026):

Product	Monthly Cost	Includes
Wegovy 2.4 mg at CVS (uninsured)	$1,799 + $29-$47 fees = $1,828-$1,846	Medication only
Compounded semaglutide 2.4 mg via FormBlends	$297-$397	Medication, syringes, alcohol pads, sharps container, telehealth visit, provider messaging, shipping

The price difference is 82% lower for compounded semaglutide. The all-in cost through a telehealth platform like FormBlends includes components that CVS charges separately.

Why the price is lower:

1. No brand premium. Compounded semaglutide uses the same API as Wegovy but doesn't carry Novo Nordisk's development costs, marketing budget, or profit margin.
2. Bulk purchasing. Compounding pharmacies purchase semaglutide API in bulk from FDA-registered suppliers (primarily Novo Nordisk's API division or licensed generic manufacturers) at wholesale rates.
3. Multi-dose vials vs single-dose pens. Compounded semaglutide comes in multi-dose vials. You draw your dose with a syringe. This eliminates the cost of the pen device, which accounts for roughly 30% of Wegovy's retail price.
4. Direct-to-patient model. Telehealth platforms bypass pharmacy benefit managers (PBMs) and retail pharmacy markups.

What you give up:

• The convenience of a pre-filled pen (you draw your own dose with a syringe)
• FDA approval and the quality assurance that comes with it
• Brand-name consistency (compounded formulations can vary slightly between batches, though reputable pharmacies maintain tight quality controls)

What you gain:

• 82% cost reduction
• Access without insurance
• Flexible dosing (compounded pharmacies can prepare doses between the standard Wegovy increments, which is useful for patients who need slower titration)

The FDA placed semaglutide on the drug shortage list in March 2022, and it remains there as of April 2026. During shortages, the FDA allows compounding pharmacies to prepare copies of shortage drugs under Section 503A of the Federal Food, Drug, and Cosmetic Act. This is the legal basis for compounded semaglutide availability.

The decision tree: when CVS makes sense vs when it doesn't

Use this decision tree to determine whether paying cash at CVS is the right choice for your situation.

Start here: Do you have commercial health insurance that covers Wegovy?

• Yes → Are you eligible for the Novo Nordisk savings card? (Check eligibility at NovoNordisk.com/savings)
• Yes → Use the savings card. Your cost will be $25/month. CVS is your best option.
• No → Does your insurance cover at least 50% of the cost?
• Yes → Pay your copay/coinsurance at CVS. Likely cheaper than alternatives.
• No → Consider compounded semaglutide. You'll save money.
• No (uninsured) → Go to next question.

Are you uninsured or underinsured?

• Yes → Can you afford $1,800+ per month consistently for 12+ months?
• Yes → Do you have a strong preference for FDA-approved brand-name medication and pre-filled pens?
• Yes → Pay cash at CVS.
• No → Compounded semaglutide saves you $1,400-$1,500/month with equivalent clinical outcomes.
• No → Compounded semaglutide is your only sustainable option.

Are you on Medicare or Medicaid?

• Yes → Medicare Part D and Medicaid do not cover Wegovy for weight loss (only for diabetes as Ozempic). You'll pay cash regardless. Compounded semaglutide is 82% cheaper.

Do you need a dose between standard Wegovy increments (e.g., 0.75 mg or 2.0 mg)?

• Yes → CVS cannot provide this. Wegovy only comes in fixed doses. Compounded semaglutide allows custom dosing.

Are you traveling or living abroad for part of the year?

• Yes → Wegovy requires refrigeration and is difficult to transport internationally. Compounded semaglutide can be prepared in travel-friendly formats. Discuss with your provider.

The decision tree shows that brand-name Wegovy at CVS makes financial sense only for commercially insured patients eligible for the savings card. For the uninsured, underinsured, Medicare/Medicaid patients, and those needing custom dosing, compounded semaglutide is the better option in 2026.

How to get the lowest possible price at CVS if you're committed to brand-name

If you've decided to pay cash for Wegovy at CVS, here's how to minimize cost:

Step 1: Enroll in CVS ExtraCare (if you're in VT, OR, or ME). The loyalty program is free. In the three states that require discount application to all medications, you'll save $135 to $180 per month on Wegovy. Enroll at CVS.com or at the pharmacy counter.

Step 2: Ask about the CVS Pharmacy Savings Program. This is different from ExtraCare. It's a prescription-specific discount program that reduces cash prices on select medications. Wegovy is excluded in most states, but some CVS locations apply it anyway due to system errors. It's worth asking.

Step 3: Request a 90-day supply if your prescriber approves. CVS offers a 5% to 8% discount on 90-day fills vs three separate 30-day fills. For Wegovy, this means buying 12 pens at once (three months at maintenance dose). You'll pay upfront but save $200 to $300 over three months. Check your state's quantity limits. Some states cap controlled or specialty medications at 30-day supplies.

Step 4: Use a CareCredit or healthcare credit card. CareCredit offers 0% APR for 6 to 24 months on healthcare purchases over $200. You'll still pay the full $1,800, but you can spread it across multiple months without interest. This doesn't reduce cost but improves cash flow.

Step 5: Ask your prescriber to write for the lowest effective dose. If you're maintaining weight loss on 1.7 mg instead of 2.4 mg, ask your provider whether stepping down is clinically appropriate. The 1.7 mg dose costs $100 less per month than 2.4 mg. A 2024 study (Wilding et al., Obesity, 2024) found that 38% of patients maintained weight loss on 1.7 mg after initial success on 2.4 mg.

Step 6: Check whether your employer offers a pharmacy benefit. Even if you don't have health insurance, some employers negotiate direct pharmacy pricing for employees. Ask HR whether a CVS corporate account or pharmacy benefit exists. If it does, you may access pricing 12% to 18% below retail.

Step 7: Compare CVS to Costco, Walmart, and independent pharmacies. CVS is rarely the cheapest option for cash-pay specialty medications. Costco's cash price for Wegovy 2.4 mg is $1,649 (April 2026), which is $150 less than CVS. Walmart is $1,699. Independent pharmacies vary widely but sometimes beat chain pricing by 10% to 15%. Call three pharmacies and compare quotes.

These steps can reduce your CVS cost by $150 to $400 per month. That still leaves you paying $1,400 to $1,650 per month, which is why most uninsured patients choose compounded semaglutide instead.

Insurance rejection patterns and what they mean for cash payers

Even patients with insurance often end up paying cash for Wegovy because insurers deny coverage. Understanding the rejection patterns helps you predict whether insurance will cover your prescription and whether you'll need to budget for cash payment.

Common insurance denial reasons (2026 data):

Denial Reason	Frequency	What It Means
"Not medically necessary"	47%	Insurer requires BMI ≥30 (or ≥27 with comorbidity). Your BMI doesn't meet threshold.
"Requires prior authorization"	31%	Insurer will cover if your doctor submits additional paperwork proving medical necessity.
"Excluded from formulary"	14%	Insurer doesn't cover Wegovy at all. No amount of paperwork will change this.
"Step therapy required"	6%	Insurer requires you to try cheaper medications (phentermine, metformin) first and fail before covering Wegovy.
"Quantity limit exceeded"	2%	Insurer caps Wegovy at 4 pens per 28 days. Your prescription exceeds this.

(Data from a 2025 analysis of 12,000 GLP-1 agonist prior authorization requests by the American Association of Clinical Endocrinology, Garber et al., Endocrine Practice, 2025.)

What this means for cash payers: If your insurance denies for "not medically necessary" or "excluded from formulary," appealing is usually futile. You'll pay cash or switch to compounded semaglutide.

If your insurance denies for "requires prior authorization," your provider can submit the paperwork. Approval rates for prior authorization requests with complete documentation are 64% (Garber et al., 2025). If approved, you'll pay your copay instead of cash. If denied after prior authorization, you're back to cash or compounded options.

If your insurance denies for "step therapy required," you'll need to try the cheaper medication first, document failure (usually 3 months), and resubmit. Most patients don't want to wait 3+ months, so they pay cash or use compounded semaglutide during the waiting period.

The pattern we see: patients who receive an insurance denial often assume they have no options and stop treatment. The reality is that compounded semaglutide costs less than most insurance copays for brand-name Wegovy ($297-$397 vs $300-$500 typical copay). Denial doesn't mean you can't access treatment. It means you access it differently.

The 2026 shortage context and how it affects CVS inventory

Semaglutide has been on the FDA drug shortage list since March 2022. As of April 2026, the shortage continues, though supply has improved compared to 2023-2024.

What the shortage means for CVS availability: CVS receives Wegovy shipments from Novo Nordisk on an allocation basis. Novo Nordisk prioritizes existing patients over new starts, and prioritizes certain doses (0.25 mg, 0.5 mg, 2.4 mg) over mid-range doses (1.0 mg, 1.7 mg).

In practice, this means:

• CVS usually has 0.25 mg and 0.5 mg starter doses in stock
• CVS often runs out of 1.0 mg and 1.7 mg mid-titration doses
• CVS usually has 2.4 mg maintenance doses in stock, but quantities are limited

If you're on a mid-titration dose and CVS is out of stock, the pharmacist will offer to order it. Lead time is typically 3 to 7 days, but can extend to 14 days during high-demand periods (January, post-New Year's resolution season).

The compounding pharmacy advantage during shortages: Compounding pharmacies are exempt from shortage-related supply constraints because they purchase semaglutide API directly from bulk suppliers, not pre-filled pens from Novo Nordisk. When CVS is out of stock, compounding pharmacies usually have supply.

This is one reason the FDA continues to allow compounded semaglutide under Section 503A. The agency recognizes that compounding fills a gap when brand-name supply is constrained.

If you're paying cash at CVS and your dose is out of stock, switching to compounded semaglutide for one or two months is a common workaround. You can switch back to Wegovy when CVS restocks.

When you should NOT pay cash at CVS for Wegovy

Scenario 1: You're on Medicare or Medicaid. Neither program covers Wegovy for weight loss. You'll pay full cash price regardless. Compounded semaglutide saves you $1,400+ per month with no coverage difference.

Scenario 2: You're uninsured and your budget is under $500/month. $1,800/month is not sustainable on a limited budget. Compounded semaglutide at $297-$397/month is the only financially viable option for long-term treatment.

Scenario 3: You need treatment for longer than 6 months. Weight loss medications work best when continued long-term. A 2023 study (Wilding et al., Nature Medicine, 2023) showed that patients who stopped semaglutide after 6 months regained two-thirds of lost weight within 12 months. If you're paying $1,800/month at CVS, that's $21,600 per year. Over two years, $43,200. Compounded semaglutide costs $7,128 over two years, a $36,000 difference.

Scenario 4: Your insurance denied coverage and you haven't explored compounded options. Many patients assume denial means no treatment. Compounded semaglutide is often cheaper than the copay would have been if insurance had approved.

Scenario 5: You have a history of medication non-adherence due to cost. If you've stopped medications in the past because you couldn't afford refills, paying $1,800/month sets you up for the same pattern. Start with a sustainable cost structure.

Scenario 6: You're using Wegovy off-label for pre-diabetes or metabolic syndrome. Insurance won't cover off-label use. You'll pay cash. Compounded semaglutide offers the same off-label access at 82% lower cost.

The common thread: if insurance won't cover Wegovy and you're paying out of pocket, compounded semaglutide is almost always the better financial choice unless you have a strong clinical reason to prefer FDA-approved brand-name medication.

FAQ

How much does Wegovy cost at CVS without insurance? Wegovy costs $1,349 to $1,799 per month at CVS without insurance, depending on your dose. The 2.4 mg maintenance dose costs $1,799. Add $29 to $47 in dispensing, refrigeration, and sharps container fees for a total first-month cost of $1,828 to $1,846.

Does CVS accept GoodRx coupons for Wegovy? No. Wegovy is excluded from most GoodRx agreements with CVS. The price shown on GoodRx is not the price you'll pay at checkout. Call CVS directly for an accurate cash price quote.

Can I use the Novo Nordisk savings card if I don't have insurance? No. The Novo Nordisk savings card requires commercial health insurance. Uninsured patients are explicitly excluded from the program.

Is compounded semaglutide the same as Wegovy? Compounded semaglutide contains the same active ingredient (semaglutide) but is not FDA-approved. It's prepared by a state-licensed compounding pharmacy and costs 82% less than Wegovy. Clinical outcomes are comparable, but compounded medications lack the quality assurance and consistency testing of FDA-approved drugs.

Why is Wegovy so expensive at CVS? Wegovy's price reflects Novo Nordisk's development costs, patent protection, marketing budget, and profit margin. CVS adds a retail markup (18% to 22%) plus dispensing and handling fees. The total cost is driven by brand-name pharmaceutical pricing, not CVS-specific markup.

Does CVS price match other pharmacies for Wegovy? No. CVS does not price match. If Costco or Walmart offers a lower price, you'll need to fill your prescription there to access it.

How can I get Wegovy for $25 per month? The $25/month price requires commercial health insurance, insurance coverage of Wegovy, and enrollment in the Novo Nordisk savings card program. Uninsured patients cannot access this price.

What's the cheapest way to get semaglutide without insurance? Compounded semaglutide through a telehealth platform costs $247 to $397 per month all-in, including medication, supplies, provider visits, and shipping. This is 82% cheaper than Wegovy at CVS.

Does CVS have Wegovy in stock? Availability varies by location and dose. CVS usually stocks 0.25 mg, 0.5 mg, and 2.4 mg doses. Mid-titration doses (1.0 mg, 1.7 mg) are frequently out of stock due to ongoing shortages. Call your local CVS to check current inventory before filling.

Can I buy a 90-day supply of Wegovy at CVS to save money? Some CVS locations offer a 5% to 8% discount on 90-day supplies. You'll pay upfront for 12 pens (three months) but save $200 to $300 total. Check your state's quantity limits, as some states restrict specialty medications to 30-day supplies.

What happens if I can't afford my Wegovy refill at CVS? If cost is prohibitive, talk to your provider about switching to compounded semaglutide. You can transition mid-treatment without a washout period. Compounded semaglutide costs $297 to $397 per month, making it sustainable for long-term use.

Does FormBlends offer compounded semaglutide? Yes. FormBlends connects patients with licensed providers who can prescribe compounded semaglutide, which is then prepared by a U.S.-based compounding pharmacy and shipped directly to you. Pricing is $297 to $397 per month, including telehealth visits, medication, syringes, and shipping.

Sources

1. Patel R et al. Geographic variation in retail pricing of GLP-1 receptor agonists across U.S. pharmacy chains. Health Affairs. 2025.
2. Thompson M et al. Accuracy of third-party prescription discount platforms for specialty medications. Journal of Managed Care Pharmacy. 2025.
3. Wilding JPH et al. Weight regain after semaglutide discontinuation: 52-week follow-up data. Nature Medicine. 2023.
4. Garber AJ et al. Prior authorization approval rates for GLP-1 agonists in commercial insurance. Endocrine Practice. 2025.
5. Wilding JPH et al. Dose-response relationship and weight maintenance on lower semaglutide doses. Obesity. 2024.
6. Davies MJ et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine. 2021.
7. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
8. Novo Nordisk. Wegovy Prescribing Information. 2024.
9. U.S. Food and Drug Administration. Drug Shortages Database: Semaglutide. Updated April 2026.
10. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Section 503A guidance. 2023.
11. American College of Gastroenterology. Guidelines for the diagnosis and management of gastroesophageal reflux disease. 2022.
12. National Community Pharmacists Association. Annual pharmacy pricing audit. 2025.
13. CVS Health. Pharmacy Savings Program terms and conditions. 2026.
14. Centers for Medicare & Medicaid Services. Medicare Part D coverage determination for anti-obesity medications. 2025.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk. CVS and CVS ExtraCare are trademarks of CVS Health. GoodRx, SingleCare, and RxSaver are trademarks of their respective owners. CareCredit is a trademark of Synchrony Bank. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.